NCT06910709View on ClinicalTrials.gov

Single and Multiple Ascending Dose Study of AMG 378 in Healthy Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 8, 2025

Primary Completion Date

October 4, 2028

Study Completion Date

October 4, 2028

Conditions
Healthy Volunteers
Interventions
DRUG

AMG 378

Oral tablet

DRUG

Placebo

Oral tablet

Trial Locations (2)

66212

RECRUITING

Dr. Vince Clinical Research, Overland Park

92630

RECRUITING

Orange County Research Center, Lake Forest

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY